Ginkgo bioworks stocks.
On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal. On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer.
Ginkgo Bioworks Holdings Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Ginkgo Bioworks Holdings Inc’s trailing 12-month revenue is $315.0 million with a -272.3% profit margin. Year-over-year quarterly sales growth most recently was -16.6%.Sep 20, 2023 · On that note, on August 29 Ginkgo Bioworks ( DNA 5.80%) announced that it is joining forces with Alphabet, Google's parent company, in a five-year strategic partnership to develop and use new ... Ginkgo Bioworks (NYSE: DNA ), Twist Bioscience (NASDAQ: TWST ), and Amyris (NASDAQ: AMRS) all fell more than 75% from peak to trough, and may still have farther to fall. Still, improving monetary ...Nov 27, 2023 · Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. [Read more] In 2022, DNA's revenue was $477.71 million, an increase of 52.21% compared to the previous year's $313.84 million. Losses were -$2.10 billion, 15.0% more than in 2021. Aug 16, 2022 · Cutting-edge biotech company Ginkgo Bioworks Holdings ( DNA -4.79%) was a popular stock on Tuesday. The cell engineering specialist's share price zoomed more than 7% higher today, thanks to ...
In the second quarter of 2022, Ginkgo Bioworks Biosecurity business generated revenue of $100 million for the company while indicating a very healthy gross profit margin of 36%. All in all, Ginkgo ...
Oct 06, 2021, 5:24 pm EDT. Shares of Ginkgo Bioworks Holdings closed down almost 12% after Scorpion Capital, a research firm focused on short selling, slammed the company as heavily reliant on ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...
Ginkgo Bioworks Holdings Inc Stock (DNA) Forecast. The Ginkgo Bioworks Holdings Inc ( DNA) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $3.8461, representing a +163.43% increase from the current price of $1.46. The highest analyst price target is $7.2822, and the lowest is $0.4100.Synthetic biology pioneer Ginkgo Bioworks agreed to go public today in a $17.5 billion SPAC deal. The Boston-based company will merge with Soaring Eagle Acquisition Corp., a blank-check firm ...Discover historical prices for DNA stock on Yahoo Finance. View daily, weekly or monthly format back to when Ginkgo Bioworks Holdings, Inc. stock was issued.Sep 17, 2021 ... More from New York Stock Exchange ; NYSE Floor Talk with Ernesto Pousada, CEO at Vibra Energia. 4 hours ago · 81 views ; NYSE Floor Talk with Pina ...Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.
Synthetic biology pioneer Ginkgo Bioworks agreed to go public today in a $17.5 billion SPAC deal. The Boston-based company will merge with Soaring Eagle Acquisition Corp., a blank-check firm ...
See Ginkgo Bioworks Holdings, Inc. (DNA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
The company has gotten a lot of attention from Wall Street, but the jury is out on whether Ginkgo can pull off its vision. One of the most bullish investors in Ginkgo Bioworks is Cathie Wood, the ...Third quarter 2023 Total revenue of $55 million, down from $66 million in the comparable prior year period, a decrease of 17% primarily driven by the expected ramp down of K-12 testing in Ginkgo's ...Ginkgo Bioworks (NYSE:DNA) Is among the more prominent stocks in the synthetic biology space. The company is located in Boston, Massachusetts, which is a …Ginkgo Bioworks' stock was trading at $1.69 at the start of the year. Since then, DNA shares have decreased by 15.4% and is now trading at $1.43. View the best growth stocks for 2023 here.Ginkgo Bioworks presently has a consensus price target of $2.25, indicating a potential upside of 57.89%. Krystal Biotech has a consensus price target of $146.56, indicating a potential upside of 37.92%. Given Ginkgo Bioworks' higher probable upside, equities research analysts plainly believe Ginkgo Bioworks is more favorable than …Dec 4, 2023 · Ginkgo Bioworks Holdings Inc (NYSE: DNA) has seen a rise in its stock price by 10.85 in relation to its previous close of 1.29. However, the company has experienced a -2.05% decline in its stock price over the last five trading sessions. The Motley Fool reported 2023-12-01 that These companies are just getting started along the path of revenue ... Ginkgo Bioworks ( DNA 5.80%) is having a strong showing today. Specifically, the synthetic biology company's shares were up by 10.1% on heavy volume as of 9:57 a.m. ET Wednesday morning. What's ...
Ark Invest has purchased more than 3.5 million shares of Ginkgo Bioworks since June 29.; The biotech company is now the fund’s 23rd largest holding. Shares of DNA stock are down over 65% year-to ...Stock Info; SEC Filings. SEC Filings; Quarterly Reports; Annual Reports; Sustainability; Governance. Executive Management; Board of Directors; Committee …A couple of stocks that have upside of 90% or more, according to analysts, are Plug Power (PLUG 1.02%) and Ginkgo Bioworks (DNA-1.44%). Are they right about these stocks, and are they good buys ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/8/23. Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you...Ginkgo Bioworks Holdings Inc’s stock is NA in 2023, NA in the previous five trading days and down 24.46% in the past year. Currently, Ginkgo Bioworks Holdings Inc does not have a price-earnings ratio. Ginkgo Bioworks Holdings Inc’s trailing 12-month revenue is $315.0 million with a -272.3% net profit margin. Year-over-year quarterly sales ...
Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ...This week was one to forget for Ginkgo Bioworks ( DNA 10.85%) shareholders. In the Monday-to-Friday period, their investment lost slightly more than 8% of its value on the stock market, according ...
Shares of Ginkgo Bioworks ( DNA 5.80%) were jumping 18.2% higher as of 10:58 a.m. ET. The nice gain came after the company announced its 2021 fourth-quarter and full-year results. Ginkgo reported ...Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis.Jan 13, 2023 ... Ginkgo is down over 85% from its peak, to $1.84 per share. Its $23 billion valuation has shrunk to $2.81 billion, quickly ending Kelly's brief ...On that note, on August 29 Ginkgo Bioworks ( DNA 5.80%) announced that it is joining forces with Alphabet, Google's parent company, in a five-year strategic partnership to develop and use new ...A high-level overview of Ginkgo Bioworks Holdings, Inc. (DNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Ginkgo Bioworks Holdings, Inc. (DNA) delivered earnings and revenue surprises of 86.67% and 16.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead ...Jun 7, 2022 · Those are some eye-opening estimates, particularly since the leader in synthetic biomanufacturing, Ginkgo Bioworks (DNA 2.16%), currently has a market cap of $6 billion and trades for a little ... Ginkgo Bioworks delivers some encouraging results. In January, Ginkgo released preliminary numbers for the full-year 2022 that indicated strong growth. The company expects its total revenue to ...As a member of the SPAC class of 2021, Ginkgo Bioworks ( NYSE: DNA) stock has seen its fair share of pummeling over the last few years. From an all-time high at ~$16 to the stock's current price ...
Ginkgo Bioworks Holdings Insider Sold Shares Worth $299,400, According to a Recent SEC Filing. MT. Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares …
1. Ginkgo Bioworks. Ginkgo Bioworks is a biotech company that went public through a special purpose acquisition company last year. The company has the backing of Bill Gates and can design and ...
Fundamentally, Ginkgo Bioworks is a mixed bag with $478 million in 2022 revenues, up 52%, but $2.1 billion in net losses also. Still, at just over $1 per share, DNA stock is poised to more than ...Aug 30, 2023 · Ginkgo Bioworks Holdings, Inc ... Buyers of the stock will need to have faith that Ginkgo can accelerate their business in the future as a PS of 12.5 for a company with operating margins of -228% ... Nov 29, 2023 · Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $299,400, According to a Recent SEC Filing. MT. Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $112,837, According to a Recent SEC Filing. MT. Summary. Quotes. Charts. Ginkgo Bioworks. Cathie Wood's Ark Invest is quickly building a position in a SPAC that plans to merge with Ginkgo Bioworks. The Ark Disruptive Innovation and Genomic Revolution ETFs doubled its ...Ginkgo trees, also known as maidenhair trees, are ancient and fascinating living fossils that have been around for millions of years. With their unique fan-shaped leaves and beautiful golden fall foliage, ginkgo trees make a stunning additi...Synthetic biology pioneer Ginkgo Bioworks agreed to go public today in a $17.5 billion SPAC deal. The Boston-based company will merge with Soaring Eagle Acquisition Corp., a blank-check firm ...Oct 18, 2023 · Ginkgo Bioworks (DNA-7.19%) sells something very original: the large-scale design and production of organisms. And thanks to its innovations, the company has increased revenue almost 800% over the ... Dec 1, 2023 · 4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.
Ginkgo Bioworks Holdings, Inc. (DNA) delivered earnings and revenue surprises of 86.67% and 16.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead ...Ginkgo Bioworks' Q2 results were poor, with soft results in both the Cell Engineering and Biosecurity businesses. ... everyone will be scrambling to buy the stock at MUCH HIGHER prices. In 2022 ...Ginkgo Bioworks (DNA 5.80%) is also a holding in the Ark Innovation ETF and the Ark Genomic Revolution ETF. The company is a leader in cell programming technology that's used in developing ...Under the terms of the merger agreement entered into on July 24, 2022, Zymergen stockholders received, for each share of Zymergen common stock, 0.9179 shares of Ginkgo Class A common stock ...Instagram:https://instagram. goldman creative planningmost consistent options strategystock analyst reportswhat is the best penny stock Ginkgo Bioworks is one of those stocks. The more it falls, the more likely it is that this will be at least a five-bagger investment by 2030. To get to that level, the stock wouldn't even need to ... eqe500best mortgage banks in ny Dec 1, 2023 · 4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price. Feb 22, 2023 · Ginkgo Bioworks delivers some encouraging results. In January, Ginkgo released preliminary numbers for the full-year 2022 that indicated strong growth. The company expects its total revenue to ... gle 63 s Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...